INSIGHTS ON LIQUID DOSE MANUFACTURING

LIQUID DOSE MANUFACTURING SOLUTIONS

  • AST’s ASEPTiCell® is a flexible fill/finish system that can efficiently process medium-sized clinical and commercial batches while meeting all cGMP requirements for cleanliness and sterility.

  • Cell and gene therapies have increased in popularity in recent years, and thanks to their ability to provide one-time treatments these therapies will play a significant role in treating some of the world's most challenging diseases. These drug products treat patients afflicted with genetic disorders and cancers by targeting the source of disease and altering its genetic makeup to eliminate its cause or symptoms. These therapies are expensive and complex and have been proven effective in numerous cases, but they present a challenge in producing them at scale and at a reasonable cost.

  • Dec’s aseptic filling equipment is configured for a seamless integration into existing production lines and designed to accommodate various containers, including sterile RTU / RTF (ready to use or fill) bottles, vials, cartridges, pre-fillable syringes and Dual Chamber Systems (DCS).

  • With over 70 years of experience in glass production, Stevanato Group, through its historic Ompi brand, is currently the market leader in cartridge manufacturing.

  • Oral non-sterile liquid manufacturing options offer a variety of liquid and suspension dosage solutions designed specifically around palatability — progressing from formulation development through full-scale commercial production.